ABCC1 and prostate carcinoma: Similarly, increased expression of multidrug-resistance-associated protein 1 (MRP1) was observed in multidrug resistant phenotype of prostate cancer, and adding non-toxic doses of MK571, zafirlukast or buthionine sulfoximine significantly increased the sensitivity of the MDR models to cytotoxic drugs [84].